Insights: DrugPatentWatch - Find Your Next Blockbuster

There is no simple way to explain drug prices, particularly in the US market, where drug prices vary considerably more than they do in other countries. Most Americans are familiar…

The post PBMs, Formularies, and Rebates: What Investors Should Know appeared first on DrugPatentWatch - Make Better Decisions.

This article was originally published by Gerard T. Vondeling, Qi Cao, Maarten J. Postma, and Mark H. Rozenbaum in Applied Health Economics and Health Policy (2018) pp.1-8 under a Creative Commons Attribution-NonCommercial…

The post The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review appeared first on DrugPatentWatch - Make Better Decisions.

Former Congressman Henry Waxman was recently interviewed for the Clause 8 podcast about how he worked together with Sen. Orrin Hatch to pass the Hatch-Waxman Act and its aftermath.  Congressman…

The post Clause 8 Podcast Interview with Co-Author of the Hatch-Waxman Act appeared first on DrugPatentWatch - Make Better Decisions.

There are more than 7,000 diseases that are considered “rare,” that is, affecting fewer than 200,000 Americans. Yet around one in ten Americans lives with at least one of these…

The post Orphan Drug Patents: Concerns Raised by Payers and Policy Makers appeared first on DrugPatentWatch - Make Better Decisions.

This article was originally published by Li Du in BMC Medical Ethics 2018 19:29 under a creative commons license. Abstract Background The patenting of human genes has been the subject…

The post Patenting human genes: Chinese academic articles’ portrayal of gene patents appeared first on DrugPatentWatch - Make Better Decisions.

Make Better Decisions: Finding and Evaluating Generic and Branded Drug Market Entry Opportunities Make Better Decisions answers the following questions to help you make the most of drug patent intelligence:…

The post Pharmaceutical Portfolio Management Reading List appeared first on DrugPatentWatch - Make Better Decisions.

This article was originally published by Christopher M. Holman in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/). Despite the important role of intellectual property rights…

The post Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection appeared first on DrugPatentWatch - Make Better Decisions.

The US pharmaceutical market, together with those of Canada and Mexico, make more than half the global pharmaceutical. The US alone is the world’s largest and it represents 45 percent of…

The post FDA Approval of New Drugs One of Many Goals for Drug Manufacturers appeared first on DrugPatentWatch - Make Better Decisions.

This paper was originally published by T. Joseph Mattingly, Joseph F. Levy, Julia F. Slejko, Nneka C. Onwudiwe, and Eleanor M. Perfetto in PharmacoEconomics Volume 36, Issue 9 under a Creative Commons…

The post Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References? appeared first on DrugPatentWatch - Make Better Decisions.

The theoretical construct of what happens when drug patents expire is simple and appealing (to consumers, anyway). A name brand drug patent expires, generics are waiting in the wings to…

The post What Happens When a Drug Patent Expires? Drug Patent Life appeared first on DrugPatentWatch - Make Better Decisions.